UnitedHealth Group Incorporated $UNH Shares Purchased by Seamount Financial Group Inc.

Seamount Financial Group Inc. boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 818 shares of the healthcare conglomerate’s stock after buying an additional 37 shares during the quarter. Seamount Financial Group Inc.’s holdings in UnitedHealth Group were worth $255,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Bayforest Capital Ltd boosted its stake in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its stake in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares during the last quarter. IAG Wealth Partners LLC purchased a new position in shares of UnitedHealth Group in the first quarter worth about $42,000. O Brien Wealth Partners LLC grew its position in shares of UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after purchasing an additional 37 shares in the last quarter. Finally, Kentucky Trust Co increased its stake in shares of UnitedHealth Group by 138.5% in the 1st quarter. Kentucky Trust Co now owns 93 shares of the healthcare conglomerate’s stock worth $49,000 after acquiring an additional 54 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $358.95 on Tuesday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $325.09 billion, a P/E ratio of 15.55, a P/E/G ratio of 2.34 and a beta of 0.47. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The company’s fifty day moving average is $309.38 and its two-hundred day moving average is $352.34.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group’s revenue was up 12.9% compared to the same quarter last year. During the same period last year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several analyst reports. Barclays lifted their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a research report on Thursday, September 4th. KeyCorp dropped their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Bank of America increased their price target on UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a research report on Monday, August 18th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Saturday, September 27th. Finally, Truist Financial increased their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.